Dr. Paul B. Chapman, MD
- Medicare services, 2024
- 52
- Medicare patients, 2024
- 27
- Part D claims, 2024
- 26
- Publications
- 106
- Clinical trials
- 6
- Practice address
- 525 East 68th Street, New York, NY 10065
- Practice phone
- Call (212) 746-5454
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Chapman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul B. Chapman is a medical oncologist in New York, New York
Dr. Chapman practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.
Dr. Chapman's NPI, 1053354936, was assigned on June 14, 2006. Dr. Chapman graduated from State University of New York Downstate Medical Center in 1981. Dr. Chapman holds New York license 174210.
- NPI
- 1053354936NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0143230524
- NPI enumeration date
- June 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (212) 746-5454
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Paul B. Chapman practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York
Dr. Chapman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.
- NewYork-Presbyterian/Weill Cornell Medical Center525 East 68th Street, New York, NY 10065 · New York CountyPhone(212) 746-5454
Source: Dmand AI Affiliation Data
Dr. Paul B. Chapman is affiliated with 4 sites of care and 2 medical groups
Dr. Chapman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Chapman to 2 more clinical labs, 1 group practice or clinic and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul B. Chapman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chapman practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| NewYork-Presbyterian/Weill Cornell Medical Center | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across NewYork-Presbyterian Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul B. Chapman is one of 458 medical oncologists in New York
Medical oncology is Dr. Chapman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Chapman is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chapman is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Chapman
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul B. Chapman billed Medicare for 52 services in 2024
CMS data shows 52 Medicare services from Dr. Chapman across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $5,572 for them. Every service was in an office.
Dr. Chapman's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3892024: 5287%
Dr. Chapman compared with the New York median for medical oncologists, 2024
- Dr. Chapman
- New York median
- Medicare services
- 52vs 34085% below
- Medicare patients
- 27vs 11276% below
- Part D claims
- 155vs 13019% above
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Chapman's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Chapman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Chapman and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul B. Chapman treated 27 Medicare patients in 2024, average age 74
CMS counts 27 Medicare patients who saw Dr. Chapman in 2024. 74% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Chapman's median patient age at 70, with 39% women.
Dr. Chapman's Medicare patients by sex, 2024
- Women1659%
- Men1141%
Chronic conditions among Dr. Chapman's Medicare patients, 2024
- High cholesterol74%
- High blood pressure67%
- Arthritis41%
- Ischemic heart disease41%
Share of Medicare patients with each condition. A patient can have several.
Dr. Chapman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women39%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Paul B. Chapman wrote 26 Medicare Part D claims in 2024
In 2024, Dr. Chapman wrote 26 Medicare Part D claims. 50% of them were for generic drugs. They cover 6 drugs, with $1,226,016 in total drug cost. In 2022, CMS named 146 claims across 7 drugs.
Dr. Chapman's Part D claims by kind of drug, 2024
- Generic13 claims50%
- Brand-name13 claims50%
Dr. Chapman's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1462023: 1556%
Drugs named by CMS: 6 in 2023, 7 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Paul B. Chapman scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chapman for performance year 2024, reported through an alternative payment model (APM). Dr. Chapman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chapman as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Chapman's MIPS scores, performance year 2024
- 100of 100Final score
- 85.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul B. Chapman has 106 publications on record
Dmand AI links 106 papers to Dr. Chapman, published from 2003 to 2024. 2015 was the busiest year, with 9. The most frequent topics are Melanoma, Skin Neoplasms and Ipilimumab. Dr. Chapman has published most often in Clin Cancer Res. Dr. Chapman's most frequent co-authors are Alexander Noor Shoushtari, MD, Jedd D. Wolchok, MD and Richard D. Carvajal, MD.
Dr. Chapman's papers by year, 2015 to 2024
Topics Dr. Chapman writes about most
- Melanoma
- Skin Neoplasms
- Ipilimumab
- Proto-Oncogene Proteins B-raf
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Nivolumab
- Antibodies, Monoclonal
Dr. Chapman's most frequent co-authors
- Alexander Noor Shoushtari, MD23 shared papers
- Jedd D. Wolchok, MD23 shared papers
- Richard D. Carvajal, MD21 shared papers
Recent publications by Dr. Chapman
Pigment Cell Melanoma Res
See who Dr. Chapman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Chapman works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul B. Chapman has worked on 6 clinical trials
Dmand AI links Dr. Chapman to 6 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Triple Negative Breast Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 3. Open Payments lists research payments to Dr. Chapman that name 1 trial.
Clinical trials with Dr. Chapman by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Chapman's trials
- Melanoma
- Nevi and Melanomas
- Triple Negative Breast Neoplasms
- Uveal Melanoma
- Uveal Neoplasms
Investigators on the most trials with Dr. Chapman
- Alexander Noor Shoushtari, MD2 shared trials
- Kristin K. Ancell, MD1 shared trial
- Pradeep G. Bhambhvani, MD1 shared trial
Recent clinical trials with Dr. Chapman
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul B. Chapman received $43,353 in industry payments from 2016 to 2025
CMS Open Payments shows 53 general payments to Dr. Chapman from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Merck Sharp & Dohme Corporation paid the most, $17,276. It also lists 2 research payments totaling $1,725 from 2018 to 2025, naming 1 clinical trial.
General payments to Dr. Chapman by program year, 2016 to 2025
General payments to Dr. Chapman by kind, 2016 to 2025
- Consulting fees$31,61273%
- Honoraria$4,37510%
- Speaker and faculty fees$3,2978%
- Travel and lodging$2,7656%
- Food and beverage$1,3043%
Companies that paid Dr. Chapman the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Paul B. Chapman graduated from State University of New York Downstate Medical Center
Dr. Chapman graduated from State University of New York Downstate Medical Center in 1981.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Paul B. Chapman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul B. Chapman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul B. Chapman's NPI number?
Dr. Paul B. Chapman's NPI number is 1053354936. It was assigned on June 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul B. Chapman?
Dr. Paul B. Chapman is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Paul B. Chapman practice?
Dr. Chapman practices at 525 East 68th Street, New York, NY 10065. Dr. Chapman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dmand AI also links Dr. Chapman to 2 clinical labs, 1 group practice or clinic and 1 medical group.
What is Dr. Paul B. Chapman's office phone number?
The practice phone on file for Dr. Chapman is (212) 746-5454.
What is Dr. Paul B. Chapman's medical license number?
Dr. Chapman holds New York license 174210.
Which hospitals is Dr. Paul B. Chapman affiliated with?
Dr. Chapman practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.
What medical group is Dr. Paul B. Chapman part of?
Dr. Chapman is linked to Weill Cornell Physicians. Dmand AI links Dr. Chapman to 1 more medical group.
Does Dr. Paul B. Chapman accept Medicare?
Yes. CMS data shows Dr. Chapman billed Medicare for 52 services in 2024, and Dr. Chapman accepts Medicare assignment.
Does Dr. Paul B. Chapman offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Chapman as offering telehealth services.
What is Dr. Paul B. Chapman's MIPS score?
Dr. Chapman's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).
Show 9 more questionsShow fewer questions
How many Medicare patients does Dr. Paul B. Chapman see?
CMS counts 27 Medicare patients who saw Dr. Chapman in 2024, with an average age of 74.
Is Dr. Paul B. Chapman board certified?
Yes. Dr. Chapman is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Paul B. Chapman bill to Medicare?
In 2024, Dr. Chapman's most billed Medicare services were office visit, established patient (99214).
Where did Dr. Paul B. Chapman go to medical school?
Dr. Chapman graduated from State University of New York Downstate Medical Center in 1981.
What drugs does Dr. Paul B. Chapman prescribe most?
In 2023 Medicare Part D data, Dr. Chapman's most prescribed drugs by claims were Levothyroxine Sodium, Braftovi and Mektovi.
Has Dr. Paul B. Chapman received payments from drug or device companies?
CMS Open Payments shows $43,353 in general payments to Dr. Chapman from 9 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Paul B. Chapman been practicing?
Dr. Chapman graduated from medical school in 1981, 45 years ago.
Does Dr. Paul B. Chapman do research?
Dmand AI links 106 publications to Dr. Chapman, published from 2003 to 2024. Dr. Chapman has worked on 6 clinical trials.
Who does Dr. Paul B. Chapman publish with?
Dr. Chapman's most frequent co-authors are Alexander Noor Shoushtari, MD (23 shared papers), Jedd D. Wolchok, MD (23 shared papers) and Richard D. Carvajal, MD (21 shared papers).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card